Federica Conte Selected Research

Federica Conte Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2016
3	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 10/2021
2	Triple Negative Breast Neoplasms 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2017
2	COVID-19 10/2021 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
1	Demyelinating Diseases (Demyelinating Disease) 06/2022
1	Multiple Sclerosis 06/2022
1	Schizophrenia (Dementia Praecox) 03/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Pathologic Processes 01/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Coronary Disease (Coronary Heart Disease) 11/2020
1	Diabetes Mellitus 11/2020
1	Lung Diseases (Lung Disease) 11/2020
1	Pulmonary Arterial Hypertension 11/2020
1	Lactose Intolerance (Intolerance, Lactose) 09/2020
1	Hypoglycemia (Reactive Hypoglycemia) 09/2020
1	Liver Failure 09/2020
1	Diarrhea 09/2020
1	Cleft Palate (Palate, Cleft) 09/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Insulin Resistance 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 06/2022 - 01/2020
4	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2020
3	Competitive Endogenous RNAIBA 01/2021 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2020
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2021 - 09/2020
2	Long Noncoding RNAIBA 08/2018 - 01/2017
1	Histamine AgentsIBA 06/2022
1	rupatadineIBA 06/2022
1	Amodiaquine (Camoquin)FDA Link 06/2022
1	Diphenhydramine (Benadryl)FDA LinkGeneric 06/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2022
1	Muramidase (Lysozyme)IBA 01/2022
1	Cytidine Monophosphate (CMP)IBA 01/2022
1	zonulinIBA 01/2022
1	Glucosamine (Dona)IBA 01/2022
1	Secretory Immunoglobulin A (SIgA)IBA 01/2022
1	Pyruvic Acid (Pyruvate)IBA 10/2021
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	NAD (NADH)IBA 10/2021
1	NucleotidesIBA 10/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	VaccinesIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	remdesivirIBA 01/2021
1	Lopinavir FDA Link 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 11/2020
1	Aurora Kinase AIBA 09/2020
1	Transaminases (Aminotransferases)IBA 09/2020
1	CB-839IBA 01/2020
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	GlutaminaseIBA 01/2020
1	NVP-BKM120IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	VemurafenibIBA 01/2019
1	DiamondIBA 08/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	TensinsIBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2021 - 11/2018
1	Immunotherapy 11/2020